ONMD
OneMedNet Corp
$0.6900
+1.92%
$35.1M
No data for this timeframe.
Vol
Market Cap$35.1M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$1.4M
Inst. Activity2 buys / 0 sells
Insider Activity4B / 0S
Insider Net $$1.7M
SEC Reports1
Press Releases2
Exchange Nasdaq·Sector Services-Commercial Physical & Biological Research·Inc. DE·CIK 0001849380·Prev Close $0.6770
Recent Activity
Jun 3, 2026
other
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
May 18, 2026
Insider
Kosasa Thomas bought 268,817 shares
Director @ $0.9300 ($250.0K)
Apr 23, 2026
Insider
Kosasa Thomas bought 280,898 shares
Director @ $0.8900 ($250.0K)
Apr 6, 2026
SEC
OneMedNet reported strong 2025 financial results with Real-World Data (RWD) revenue surging 329% year-over-year to $1.25
PRESS-RELEASE — Impact 8/10
Apr 1, 2026
Press
OneMedNet announced a pilot collaboration with Inka Health, a subsidiary of Onco-Innovations, granting access to its iRW
Impact 4/10
Apr 1, 2026
Insider
Yu Jeffrey sold 219,429 shares
Chief Medical Officer @ $0.8300 ($182.1K)
Inst.
VANGUARD GROUP INC — ADD
1,301,306 shares ($1.4M)
Inst.
RENAISSANCE TECHNOLOGIES LLC — NEW
11,116 shares ($12.2K)
Latest Reports
BULLISH
PRESS-RELEASE
8/10
OneMedNet reported strong 2025 financial results with Real-World Data (RWD) revenue surging 329% year-over-year to $1.25
Apr 6, 2026
NEUTRAL
Press
4/10
OneMedNet announced a pilot collaboration with Inka Health, a subsidiary of Onco-Innovations, granting access to its iRW
Apr 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $1.4M | ADD |
| RENAISSANCE TECHNOLOGIES LLC | $12.2K | NEW |
| BANK OF AMERICA CORP | $282.00 | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 18, 2026 | Kosasa Thomas | BUY | $250.0K |
| Apr 23, 2026 | Kosasa Thomas | BUY | $250.0K |
| Apr 1, 2026 | Yu Jeffrey | A | $182.1K |
| Apr 1, 2026 | Yu Jeffrey | BUY | $750.0K |
| Feb 6, 2026 | Kosasa Thomas | BUY | $500.0K |
3 institutional holders with $1.4M total value (1,312,678 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, BANK. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,301,306 | $1.4M | 99.1% | ADD +32.5% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 11,116 | $12.2K | 0.8% | NEW |
| 3 | BANK OF AMERICA CORP /DE/ | 256 | $282.00 | 0.0% | ADD +72.2% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | ADD | 982,239 | 1,301,306 | +32.5% | $1.4M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 11,116 | — | $12.2K | 2025-Q4 |
| VANGUARD GROUP INC | ADD | 747,500 | 982,239 | +31.4% | $1.1M | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 11,836 | 653 | -94.5% | $712.00 | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 133 | 229 | +72.2% | $249.00 | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 103 | 133 | +29.1% | $75.00 | 2025-Q2 |
| VANGUARD GROUP INC | DOUBLED | 44,500 | 747,500 | +1579.8% | $401.4K | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 37,731 | 28,058 | -25.6% | $15.1K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 10,845 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | TRIM | 37,766 | 20,378 | -46.0% | $27.7K | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 16,500 | 10,845 | -34.3% | $14.7K | 2024-Q4 |
2 unique insiders with 4 transactions. Net insider value: $1.7M ($1.7M bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 18, 2026 | Kosasa Thomas | Director | BUY | 268,817 | $0.9300 | $250.0K |
| Apr 23, 2026 | Kosasa Thomas | Director | BUY | 280,898 | $0.8900 | $250.0K |
| Apr 1, 2026 | Yu Jeffrey | Chief Medical Officer | A | 219,429 | $0.8300 | $182.1K |
| Apr 1, 2026 | Yu Jeffrey | Chief Medical Officer | BUY | 903,614 | $0.8300 | $750.0K |
| Feb 6, 2026 | Kosasa Thomas | Director | BUY | 595,238 | $0.8400 | $500.0K |
1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 8.0/10.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 3, 2026
other
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
Apr 6, 2026
earnings
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medica
Apr 1, 2026
contract
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data
Mar 18, 2026
contract
OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
Mar 2, 2026
short_interest
FTD: ONMD — 1,666,891 shares ($1.7M) failed to deliver
Settlement: 20260302, Price: $1.02, FTD Value: $1,700,228.82, ONEMEDNET CORP CL A